Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

Biotechnology

Angion

The San Francisco office likely focuses on executive leadership, strategic development, and high-level decision-making.

San Francisco

Angion's headquarters in Uniondale, NY, United States

Jay Venkatesan

Greg Curhan

Karen J. Wilson

Matthew R. Weir

Joseph Bonventre

Anupam Agarwal

Sumit Mohan

Victor F. Ganzi

Gilbert S. Omenn

Allen R. Nissenson

Michael Koren

Ken Newell

Gregory P. Downey

Jack Boyd

Matthew Cooper

The Scientific Advisory team at Angion provides expert guidance on the design and implementation of research initiatives, ensuring the scientific validity and innovation of therapeutic candidates. Comprising multiple advisors, the team collaborates to evaluate clinical data, inform strategic decisions, and advance the development of novel treatments for acute organ injuries and fibrotic diseases. Their insights help shape the company’s research direction and enhance the overall efficacy of the therapeutic pipeline.

Scientific Advisory

The Leadership Team at Angion is responsible for driving the strategic direction and operational excellence of the company. This team, composed of key executives including the CEO, CFO, and Chief Scientific Officer, collaborates to advance the development and commercialization of innovative therapeutics, ensuring alignment with company goals while overseeing financial health, scientific innovation, and regulatory compliance. Their collective expertise supports Angion’s mission to address critical healthcare challenges in acute organ injuries and fibrotic diseases.

Leadership Team

Angion

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Offices

Angion

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Offices

Related companies